Mepindolol is a 2-methyl derivative of pindolol. It is a beta blocker.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Mepindolol may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Mepindolol may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Mepindolol. |
| Amiodarone | The therapeutic efficacy of Mepindolol can be increased when used in combination with Amiodarone. |
| Bupivacaine | The serum concentration of Bupivacaine can be increased when it is combined with Mepindolol. |
| Dipyridamole | Dipyridamole may increase the bradycardic activities of Mepindolol. |
| Disopyramide | Disopyramide may increase the bradycardic activities of Mepindolol. |
| Dronedarone | Dronedarone may increase the bradycardic activities of Mepindolol. |
| Fingolimod | Mepindolol may increase the bradycardic activities of Fingolimod. |
| Floctafenine | The risk or severity of adverse effects can be increased when Mepindolol is combined with Floctafenine. |
| Mepivacaine | The serum concentration of Mepivacaine can be increased when it is combined with Mepindolol. |
| Methacholine | Mepindolol may increase the bronchoconstrictory activities of Methacholine. |
| Midodrine | The therapeutic efficacy of Midodrine can be decreased when used in combination with Mepindolol. |
| Nifedipine | The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Mepindolol. |
| Propafenone | The risk or severity of adverse effects can be increased when Propafenone is combined with Mepindolol. |
| Regorafenib | Regorafenib may increase the bradycardic activities of Mepindolol. |
| Reserpine | Reserpine may increase the hypotensive activities of Mepindolol. |
| Deserpidine | Deserpidine may increase the hypotensive activities of Mepindolol. |
| Guanethidine | Guanethidine may increase the hypotensive activities of Mepindolol. |
| Rivastigmine | Mepindolol may increase the bradycardic activities of Rivastigmine. |
| Mirabegron | The serum concentration of Mepindolol can be increased when it is combined with Mirabegron. |
| Insulin argine | Mepindolol may increase the hypoglycemic activities of Insulin argine. |
| Nicotine | The risk or severity of adverse effects can be increased when Mepindolol is combined with Nicotine. |
| Cevimeline | The risk or severity of adverse effects can be increased when Mepindolol is combined with Cevimeline. |
| Carbamoylcholine | The risk or severity of adverse effects can be increased when Mepindolol is combined with Carbamoylcholine. |
| Bethanechol | The risk or severity of adverse effects can be increased when Mepindolol is combined with Bethanechol. |
| Pilocarpine | The risk or severity of adverse effects can be increased when Mepindolol is combined with Pilocarpine. |
| Varenicline | The risk or severity of adverse effects can be increased when Mepindolol is combined with Varenicline. |
| Acetylcholine | The risk or severity of adverse effects can be increased when Mepindolol is combined with Acetylcholine. |
| Arecoline | The risk or severity of adverse effects can be increased when Mepindolol is combined with Arecoline. |
| Lobeline | The risk or severity of adverse effects can be increased when Mepindolol is combined with Lobeline. |
| NGX267 | The risk or severity of adverse effects can be increased when Mepindolol is combined with NGX267. |
| GTS-21 | The risk or severity of adverse effects can be increased when Mepindolol is combined with GTS-21. |
| Epibatidine | The risk or severity of adverse effects can be increased when Mepindolol is combined with Epibatidine. |
| Xanomeline | The risk or severity of adverse effects can be increased when Mepindolol is combined with Xanomeline. |
| Thiethylperazine | The serum concentration of Mepindolol can be increased when it is combined with Thiethylperazine. |
| Promazine | The serum concentration of Mepindolol can be increased when it is combined with Promazine. |
| Prochlorperazine | The serum concentration of Mepindolol can be increased when it is combined with Prochlorperazine. |
| Triflupromazine | The serum concentration of Mepindolol can be increased when it is combined with Triflupromazine. |
| Fluphenazine | The serum concentration of Mepindolol can be increased when it is combined with Fluphenazine. |
| Moricizine | The serum concentration of Mepindolol can be increased when it is combined with Moricizine. |
| Trifluoperazine | The serum concentration of Mepindolol can be increased when it is combined with Trifluoperazine. |
| Perphenazine | The serum concentration of Mepindolol can be increased when it is combined with Perphenazine. |
| Mesoridazine | The serum concentration of Mepindolol can be increased when it is combined with Mesoridazine. |
| Acetophenazine | The serum concentration of Mepindolol can be increased when it is combined with Acetophenazine. |
| Promethazine | The serum concentration of Mepindolol can be increased when it is combined with Promethazine. |
| Alimemazine | The serum concentration of Mepindolol can be increased when it is combined with Alimemazine. |
| Periciazine | The serum concentration of Mepindolol can be increased when it is combined with Periciazine. |
| Acepromazine | The serum concentration of Mepindolol can be increased when it is combined with Acepromazine. |
| Aceprometazine | The serum concentration of Mepindolol can be increased when it is combined with Aceprometazine. |
| Pipotiazine | The serum concentration of Mepindolol can be increased when it is combined with Pipotiazine. |
| Thioproperazine | The serum concentration of Mepindolol can be increased when it is combined with Thioproperazine. |
| BL-1020 | The serum concentration of Mepindolol can be increased when it is combined with BL-1020. |
| Cyamemazine | The serum concentration of Mepindolol can be increased when it is combined with Cyamemazine. |
| Methylene blue | The serum concentration of Mepindolol can be increased when it is combined with Methylene blue. |
| Propiopromazine | The serum concentration of Mepindolol can be increased when it is combined with Propiopromazine. |
| Perazine | The serum concentration of Mepindolol can be increased when it is combined with Perazine. |
| Butaperazine | The serum concentration of Mepindolol can be increased when it is combined with Butaperazine. |
| Chlorproethazine | The serum concentration of Mepindolol can be increased when it is combined with Chlorproethazine. |
| Thiazinam | The serum concentration of Mepindolol can be increased when it is combined with Thiazinam. |
| Dixyrazine | The serum concentration of Mepindolol can be increased when it is combined with Dixyrazine. |
| Perphenazine enanthate | The serum concentration of Mepindolol can be increased when it is combined with Perphenazine enanthate. |
| Digoxin | Mepindolol may increase the bradycardic activities of Digoxin. |
| Acetyldigitoxin | Mepindolol may increase the bradycardic activities of Acetyldigitoxin. |
| Deslanoside | Mepindolol may increase the bradycardic activities of Deslanoside. |
| Ouabain | Mepindolol may increase the bradycardic activities of Ouabain. |
| Digitoxin | Mepindolol may increase the bradycardic activities of Digitoxin. |
| Oleandrin | Mepindolol may increase the bradycardic activities of Oleandrin. |
| Cymarin | Mepindolol may increase the bradycardic activities of Cymarin. |
| Proscillaridin | Mepindolol may increase the bradycardic activities of Proscillaridin. |
| Metildigoxin | Mepindolol may increase the bradycardic activities of Metildigoxin. |
| Lanatoside C | Mepindolol may increase the bradycardic activities of Lanatoside C. |
| Gitoformate | Mepindolol may increase the bradycardic activities of Gitoformate. |
| Acetyldigoxin | Mepindolol may increase the bradycardic activities of Acetyldigoxin. |
| Peruvoside | Mepindolol may increase the bradycardic activities of Peruvoside. |
| Lidocaine | The serum concentration of Lidocaine can be increased when it is combined with Mepindolol. |
| Icosapent | Icosapent may decrease the antihypertensive activities of Mepindolol. |
| Mesalazine | The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Mepindolol. |
| Indomethacin | Indomethacin may decrease the antihypertensive activities of Mepindolol. |
| Nabumetone | Nabumetone may decrease the antihypertensive activities of Mepindolol. |
| Ketorolac | Ketorolac may decrease the antihypertensive activities of Mepindolol. |
| Tenoxicam | Tenoxicam may decrease the antihypertensive activities of Mepindolol. |
| Celecoxib | Celecoxib may decrease the antihypertensive activities of Mepindolol. |
| Tolmetin | Tolmetin may decrease the antihypertensive activities of Mepindolol. |
| Rofecoxib | Rofecoxib may decrease the antihypertensive activities of Mepindolol. |
| Piroxicam | Piroxicam may decrease the antihypertensive activities of Mepindolol. |
| Fenoprofen | Fenoprofen may decrease the antihypertensive activities of Mepindolol. |
| Valdecoxib | Valdecoxib may decrease the antihypertensive activities of Mepindolol. |
| Diclofenac | Diclofenac may decrease the antihypertensive activities of Mepindolol. |
| Sulindac | Sulindac may decrease the antihypertensive activities of Mepindolol. |
| Flurbiprofen | Flurbiprofen may decrease the antihypertensive activities of Mepindolol. |
| Etodolac | Etodolac may decrease the antihypertensive activities of Mepindolol. |
| Mefenamic acid | Mefenamic acid may decrease the antihypertensive activities of Mepindolol. |
| Naproxen | Naproxen may decrease the antihypertensive activities of Mepindolol. |
| Sulfasalazine | Sulfasalazine may decrease the antihypertensive activities of Mepindolol. |
| Phenylbutazone | Phenylbutazone may decrease the antihypertensive activities of Mepindolol. |
| Meloxicam | Meloxicam may decrease the antihypertensive activities of Mepindolol. |
| Carprofen | Carprofen may decrease the antihypertensive activities of Mepindolol. |
| Diflunisal | Diflunisal may decrease the antihypertensive activities of Mepindolol. |
| Salicylic acid | Salicylic acid may decrease the antihypertensive activities of Mepindolol. |